Literature DB >> 6388953

Cigarette smoking pharmacokinetics and its relationship to smoking behaviour.

T D Darby, J E McNamee, J M van Rossum.   

Abstract

The yield of a cigarette is determined by the tobacco blend, the length of the cigarette, the cigarette paper, the filter and air dilution. Cigarette yield has been defined by tradition and by law to be the yield of nicotine, tar and carbon monoxide obtained from a 35 ml puff volume of 2-second duration taken every minute during the burning time of the cigarette. Normally smokers draw a puff into their mouth and then inhale. Mouth delivery is largely determined by personal smoking behaviour. The puff volume, number of puffs taken per cigarette, and number of cigarettes smoked per day determine both the volume and the mass of daily mouth delivery. There are marked differences in smoking behaviour, and the delivery is substantially altered from the yield values obtained with the standardised test procedure. Body uptake of smoke ingredients is determined by smoke chemical parameters, smoker inhalation behaviour, lung morphology, and physiological parameters. The physiological parameters include tidal volume, vital capacity, rate of breathing, and rate of clearance for the lung. Given these behavioural and physiological differences in individual delivery and uptake it is not surprising that differences in measured parameters occur within smokers of cigarettes with a particular yield. Biological differences among individuals, such as metabolic and size differences, cause additional variations in these values. Therefore, the estimates of nicotine and tar delivery can vary widely in studies of individual uptake when the estimates are based upon sample population data. The variables in both smoking behaviour and in chemical and physiological factors which alter uptake make it essential to have a crossover design for any study. The large standard error for the plasma concentration of cotinine (a major metabolite of nicotine) within a sample population, and the log linear nature of the plasma cotinine concentration curve, requires a very large sample size for any study of cigarette delivery or uptake. When comparisons of brands are made, average values are misleading in that the skew to the high values obscures frequency differences among the lower values within the samples. It is important to remember that smoker compliance with study design is very essential.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388953     DOI: 10.2165/00003088-198409050-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  24 in total

1.  Short-term effects of cigarette smoking on bronchial clearance in humans.

Authors: 
Journal:  Arch Environ Health       Date:  1975-07

Review 2.  Deposition of aerosol in the respiratory tract.

Authors:  J D Brain; P A Valberg
Journal:  Am Rev Respir Dis       Date:  1979-12

3.  Smoker intake from cigarettes in the 1-mg Federal Trade Commission tar class.

Authors:  G B Gori; C J Lynch
Journal:  Regul Toxicol Pharmacol       Date:  1983-06       Impact factor: 3.271

4.  Interindividual variations in drug disposition. Clinical implications and methods of investigation.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

Review 5.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

6.  Monitoring smoking patterns of low and high tar cigarettes with inductive plethysmography.

Authors:  M J Tobin; M A Sackner
Journal:  Am Rev Respir Dis       Date:  1982-08

7.  Pharmacologic considerations in the design of toxicology experiments.

Authors:  T D Darby
Journal:  Clin Toxicol       Date:  1978-02       Impact factor: 4.467

Review 8.  Update on the role of cigarette smoking in coronary artery disease.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1981-03       Impact factor: 4.749

9.  Cotinine disposition and effects.

Authors:  N L Benowitz; F Kuyt; P Jacob; R T Jones; A L Osman
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

10.  Smokers of low-yield cigarettes do not consume less nicotine.

Authors:  N L Benowitz; S M Hall; R I Herning; P Jacob; R T Jones; A L Osman
Journal:  N Engl J Med       Date:  1983-07-21       Impact factor: 91.245

View more
  11 in total

Review 1.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

2.  Paced smoking in the laboratory and in the natural smoking setting: differential situation-specific effects in light and heavy smokers.

Authors:  P E Schupp; R F Mucha; P Pauli
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

Review 3.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

4.  Long-term effects of switching to cigarettes with lower tar and nicotine yields.

Authors:  A R Guyatt; A J Kirkham; D C Mariner; A G Baldry; G Cumming
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Elimination of cotinine from body fluids: disposition in smokers and nonsmokers.

Authors:  N J Haley; D W Sepkovic; D Hoffmann
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

Review 6.  The metabolic function of the lung.

Authors:  W J Wijnands
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

7.  Comparison of measured and FTC-predicted nicotine uptake in smokers.

Authors:  G D Byrd; J H Robinson; W S Caldwell; J D deBethizy
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

Review 8.  Clinical pharmacokinetics of nicotine.

Authors:  C K Svensson
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 9.  Nicotine: A Double-Edged Sword in Atherosclerotic Disease.

Authors:  Chun-Chieh Liu; Hung-I Yeh
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

10.  Kinetics of cotinine after oral and intravenous administration to man.

Authors:  P J De Schepper; A Van Hecken; P Daenens; J M Van Rossum
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.